A new, powerful Citizen Portal experience is ready. Switch now

Panel approves measure allowing qualified hospital pharmacists to administer emergency medications under physician direction

February 03, 2026 | 2026 Legislature FL, Florida


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Panel approves measure allowing qualified hospital pharmacists to administer emergency medications under physician direction
Representative Young presented HB 1021 as a narrow patient‑safety measure allowing qualified hospital pharmacists embedded on trauma teams in level-1 and level-2 centers, and only at a physician's direction, to administer emergency medications during life‑threatening events. Sponsor stressed the bill is limited to physician‑directed administration and applies only in high‑acuity trauma settings.

Committee members asked about the definition of life‑threatening events, whether physician assistants or nurse practitioners could direct administration, whether there would be a cap on pharmacists administering medications in a single emergency department, and whether hospitals would be covered by the statutory change. Representative Young said the bill requires physician direction as defined under chapters 458 and 459, described board‑certification and postgraduate requirements for pharmacists to qualify, and offered a technical amendment to ensure the statute applies to hospitals under chapter 395; the amendment was adopted.

Members praised the sponsor—several noted it was his first bill—and the committee voted 16-0 to report HB 1021 favorably.

Don't Miss a Word: See the Full Meeting!

Go beyond summaries. Unlock every video, transcript, and key insight with a Founder Membership.

Get instant access to full meeting videos
Search and clip any phrase from complete transcripts
Receive AI-powered summaries & custom alerts
Enjoy lifetime, unrestricted access to government data
Access Full Meeting

30-day money-back guarantee